COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?

Published:2021-09 Issue:9 Volume:27 Page:1376-1378
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Fekkar Arnaud,Neofytos Dionysios,Nguyen Minh-Hong,Clancy Cornelius J.,Kontoyiannis Dimitrios P.,Lamoth Frederic

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference23 articles.

1. Defining and managing covid-19-associated pulmonary aspergillosis: the 2020 ecmm/isham consensus criteria for research and clinical guidance;Koehler;Lancet Infect Dis,2021

2. Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with covid-19;Alanio;Lancet Respir Med,2020

3. Covid-19 associated pulmonary aspergillosis;Koehler;Mycoses,2020

4. Covid-19 associated pulmonary aspergillosis;van Arkel;Am J Respir Crit Care Med,2020

5. Covid-19 associated pulmonary aspergillosis (CAPA) in patients admitted with severe covid-19 pneumonia: an observational study from Pakistan;Nasir;Mycoses,2020

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting COVID 19–Associated Pulmonary Aspergillosis Risk in Low- and Middle-Income Countries: A Matched Case-Control Study;Open Forum Infectious Diseases;2024-06-28

2. Prospective and systematic screening for invasive aspergillosis in the ICU during the COVID-19 pandemic, a proof of principle for future pandemics;Medical Mycology;2024-03-27

3. Risk factors for COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis;The Lancet Respiratory Medicine;2024-03

4. Clinical characteristics, bacterial coinfections and outcomes in COVID‐19‐associated pulmonary aspergillosis in a third‐level Mexican hospital during the COVID‐19 pre‐vaccination era;Mycoses;2024-01

5. Post-Viral Aspergillosis;Infectious Diseases;2023-11-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3